期刊文献+

影响非手术治疗肝门部胆管癌预后因素分析 被引量:3

ANALYSIS OF FACTORS LNFLUENCING PROGNOSIS OF PATIENTS UNDERWENT HILAR CARCINOMA WOTHOUT RESECTION
下载PDF
导出
摘要 目的 分析影响非手术肝门部胆管癌预后因素。方法 对我院2002年~2007年期间有明显手术禁忌的43位患者进行研究。本组患者中接受内镜支架引流者27例,接受经皮经肝穿刺引流患者16例。选择可能影响非手术肝门部胆管癌的临床病理因素,并通过Kaplan—Meier曲线进行分析。结果 全组非手术肝门部胆管癌患者平均生存期为289天。单因素分析提示,患者初始胆红素水平影响肝门部胆管癌的预后。Kaplan-Meier曲线分析提示,初始胆红素〉171umol/L的生存期少于初始胆红素〈171umol/L的患者。结论 影响非手术肝门部胆管癌患者预后的较重要的因素是患者初始胆红素水平,而ERBD和PTBD引流对患者生存期影响无明显差异。 Objective To analysis the factors influencing the prognosis of patients underwent hilar carcinoma without resection. Methods The clinical dates of 43 patients receiving palliative endoscopic transpapillary ( n = 27 ) or percutaneous transhepatic biliary drainage( n = 16) in our hospital from 2002 to 2007 were collected retrospectively and clinicopathologic factors that might influence survival were analyzed, a survival factor analysis were performed through Kaplan-Meier cure and log-rank test. Results All of the 43 patients were with an average of 289 days. The single factor analysis showed that the major significant factor influencing survival of these patients was initial bilirubin level( P 〈 0. 05 ). Initial bilirubin level was found to be the statistically significant factor influencing survival by Kaplan-Meier cure. Conclusion The most important prognostic factor for bile duct carcinoma without resection was initial bilirubin level ,the type of biliary-drainage( ERBD or PTBD ) had no significant beneficial effect on the mean of survival time.
出处 《肝胆外科杂志》 2008年第4期281-283,共3页 Journal of Hepatobiliary Surgery
  • 相关文献

参考文献1

二级参考文献30

  • 1Jarnagin WR,Fong Y,DeMatteo RP,Gonen M,Burke EC,Bodniewicz BS J, Youssef BAM,Klimstra D,Blumgart LH.Staging,resectability,and outcome in 225 patients with hilar cholangiocarcinoma.Ann Surg 2001: 234:507-517.
  • 2Burke EC,Jarnagin WR,Hochwald SN,Pisters PW,Fong Y,Blumgart LH. Hilar Cholangiocarcinoma:patterns of spread,the importance of hepatic resection for curative operation,and a presurgical clinical staging system.Ann Surg 1998;228:385-394.
  • 3Havlik R,Sbisa E,Tullo A,Kelly MD,Mitry RR,Jiao LR,Mansour MR,Honda K,Habib NA.Results of resection for hilar cholangiocarcinoma with analysis of prognostic factors.Hevatogastroenterology 2000: 47:927-931.
  • 4Tumours of the biliary tract.In Robert L.Souhami,Ian Tannock(eds). Oxford Textbook of Oncology.OXFORD University Press 2002:1641-1652.
  • 5Reed DN Jr,Vitale GC,Martin R,Bas H,Wieman TJ,Larson GM,Edwards M, McMasters K.Bile duct carcinoma:trendsin treatment in the nineties. Am Surg 2000; 66:711-714.
  • 6Figueras J,Llado L,Valls C,Serrano T,Ramos E,Fabregat J,Rafecas A, Torras J,Jaurrieta E.Changing strategies in diagnosis and management of hilar cholangiocarcinoma.Liver Transpl 2000.6:786-794.
  • 7Nimura Y,Kamiya J,Kondo S,Nagino M,Uesaka K,Oda K,Sano T,Yamamoto H, Hayakawa N.Aggressive preoperative management and extended surgery for hilar cholangiocarcinoma:Nogoya experience.J Hepatobiliary Pancreat Surg 2000;7:155-162.
  • 8Bathe OF,Pacheco JT,Ossi PB,Hamilton KL,Franceschi D,Sleeman D,Levi JU,Livingstone AS.Management of hilar bile duct carcinoma. Hepatogastroenterology 2001;48:1289-1294.
  • 9Chamberlain RS,Blumgart LH.Hilar cholangiocarcinoma:a review and commentarv.Ann Surf Oncol 2000;7:55-66.
  • 10Fletcher MS,Brinkley D,Dawson JL,Nunnerley H,Williams R.Treatment of hilar carcinoma by bile drainage combined with internal radiotherapy using 192iridium wire.Br J Surg 1983;70:733-735.

共引文献6

同被引文献18

引证文献3

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部